The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of BTN2A1+ microvesicles with overall survival and the role of γδ T cells as a potential therapeutic target in patients with hormone-sensitive metastatic prostate cancer.
 
Emilien Billon
No Relationships to Disclose
 
Caroline Imbert
No Relationships to Disclose
 
Laurent Gorvel
No Relationships to Disclose
 
Manon Richaud
No Relationships to Disclose
 
Rania Ghossoub
No Relationships to Disclose
 
Virginie Girault
No Relationships to Disclose
 
Thierry Fest
No Relationships to Disclose
 
Gwenaelle Gravis
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); BMS (Inst); Curium Pharma (Inst); Janssen (Inst); Merck/Pfizer (Inst)
Speakers' Bureau - Advanced Accelerator Applications (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); Pfizer/EMD Serono (Inst)
Research Funding - BMS (Inst)
Expert Testimony - BAYER (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Pfizer
 
Daniel Olive
Stock and Other Ownership Interests - Alderaan Biotechnology; GlaxoSmithKline; Imcheck Therapeutics
Research Funding - Imcheck Therapeutics